EichorEICHOR
Location: Westmead Synced from ClinicalTrials.gov · August 08, 2026

Clinical studies recruiting near Westmead

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

Precision Medicine for Every Child With Cancer
Phase N/A · Australian & New Zealand Children's Haematology/Oncology Gro · NCT05504772A Global Study of Novel Agents in Paediatric and Adolescent Relapsed and Refractory B-cell Non-Hodgkin Lymphoma
Phase 2/Phase 3 · University of Birmingham · NCT05991388Interfant-21 Treatment Protocol for Infants Under 1 Year With KMT2A-rearranged ALL or Mixed Phenotype Acute Leukemia
Phase 3 · The Childrens Hospital at Westmead · Princess Maxima Center for Pediatric Oncology · NCT05327894Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
Phase 3 · Westmead Hospital ( Site 2700) · Merck Sharp & Dohme LLC · NCT06393374A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) G
Phase 1/Phase 2 · The Children's Hospital at Westmead · National Cancer Institute (NCI) · NCT05099003Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed
Phase 3 · The Children's Hospital at Westmead · National Cancer Institute (NCI) · NCT06172296Study of WAL0921 in Patients With Glomerular Kidney Diseases
Phase 2 · Westmead Hospital · Walden Biosciences · NCT06466135IKS03 in Patients With Advanced B Cell Non-Hodgkin Lymphomas
Phase 1 · Westmead Hospital · Iksuda Therapeutics Ltd. · NCT05365659A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have or Have Not Been Treated With Biologic Medicines
Phase 3 · Westmead Hospital · Takeda · NCT06671496A Study to Investigate Efficacy and Safety of Pegtibatinase Compared With Placebo in Participants ≥12 to ≤65 Years of Ag
Phase 3 · Westmead Hospital · Travere Therapeutics, Inc. · NCT06247085A Study to Evaluate the Long-term Safety and Tolerability of KarXT and KarX-EC for the Treatment of Schizophrenia and Au
Phase 3 · Local Institution - 0107 · Karuna Therapeutics, Inc., a Bristol Myers Squibb company · NCT07424404A Study to Evaluate the Safety and Tolerability of Pumitamig Alone or In Combination With Ipilimumab in Participants Wit
Phase 1/Phase 2 · Local Institution - 0033 · Bristol-Myers Squibb · NCT07291076A Study of Lower Radiotherapy Dose to Treat Children With CNS Germinoma
Phase 2 · The Children's Hospital at Westmead · Children's Oncology Group · NCT06368817A Study to Test the Addition of the Drug Cabozantinib to Chemotherapy in Patients With Newly Diagnosed Osteosarcoma
Phase 2/Phase 3 · The Children's Hospital at Westmead · National Cancer Institute (NCI) · NCT05691478Ultra-Early, Minimally inVAsive intraCerebral Haemorrhage evacUATion Versus Standard trEatment
NA · University of Melbourne · NCT04434807A Study of Zasocitinib in Adults With Hidradenitis Suppurativa
Phase 2 · Westmead Hospital · Takeda · NCT07244263Quality of Pediatric Resuscitation in a Multicenter Collaborative
Phase N/A · The Children's Hospital at Westmead · Children's Hospital of Philadelphia · NCT02708134Combination Therapy for the Treatment of Diffuse Midline Gliomas
Phase 2 · The Children's Hospital at Westmead · University of California, San Francisco · NCT05009992A Study of Baricitinib (LY3009104) to Preserve Beta Cell Function in Children and Adults Newly Diagnosed With Type 1 Dia
Phase 3 · The Children's Hospital at Westmead · Eli Lilly and Company · NCT07222332A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT
Phase 2 · The Children's Hospital at Westmead · Children's Oncology Group · NCT04322318A Phase 3, Placebo-Controlled Study to Investigate LP352 in Children and Adults With Dravet Syndrome (DS)
Phase 3 · Children's Hospital at Westmead · Longboard Pharmaceuticals · NCT06660394A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previ
Phase 3 · Westmead Hospital · Pfizer · NCT07144280ROADMAP Clinical Trial
Phase 4 · Westmead Hospital · University of Newcastle, Australia · NCT06771050DPX-Survivac and Pembrolizumab With and Without Intermittent Low-Dose Cyclophosphamide, in Subjects With Relapsed/Refrac
Phase 2 · Westmead Hospital · ImmunoVaccine Technologies, Inc. (IMV Inc.) · NCT04920617Phase 1 Study to Evaluate the Safety and Tolerability of Intravenously Administered PYC-003
Phase 1 · Westmead Hospital, Clinical Research Unit, Level 6, B Wing/B · PYC Therapeutics · NCT06714006EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagliflozin)
Phase 3 · Boehringer Ingelheim · NCT06531824A Study to Learn More About the Effects and Safety of Felzartamab Infusions in Adults With Primary Membranous Nephropath
Phase 3 · Westmead Hospital · Biogen · NCT06962800SAFety and Efficacy of Human Anti-thymocyte ImmunoGlobUlin SAB-142 ARresting Progression of Type 1 Diabetes
Phase 2 · Westmead Hospital · SAb Biotherapeutics, Inc. · NCT07187531Conquer-AF Protocol for Redo Ablation Procedures in Recurrent Paroxysmal and Persistent Atrial Fibrillation Using the Sp
NA · Westmead Hospital · Medtronic Cardiac Ablation Solutions · NCT07298473Improving Therapeutic Drug Monitoring and Dosing for Vancomycin in Young Infants With Infections (VANCAPP) (Part 2)
Phase 4 · Murdoch Childrens Research Institute · NCT05770622
Look up another city
Look up another condition
Eichor
Clinical intelligence from public evidence
Use of Eichor is governed by our Terms of Use · Privacy Policy
© 2026 Biomedistats LLC (dba Eichor)

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.